| __timestamp | Ascendis Pharma A/S | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 1244910 |
| Thursday, January 1, 2015 | 9415000 | 5029636 |
| Friday, January 1, 2016 | 11504000 | 4846776 |
| Sunday, January 1, 2017 | 13482000 | 5329003 |
| Monday, January 1, 2018 | 25057000 | 7121000 |
| Tuesday, January 1, 2019 | 48473000 | 9128000 |
| Wednesday, January 1, 2020 | 76669000 | 10731000 |
| Friday, January 1, 2021 | 160180000 | 10701000 |
| Saturday, January 1, 2022 | 221227000 | 16121000 |
| Sunday, January 1, 2023 | 264410000 | 37021000 |
| Monday, January 1, 2024 | 284545000 |
Cracking the code
In the competitive world of biotechnology, managing operational expenses is crucial for success. Ascendis Pharma A/S and Viking Therapeutics, Inc. have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. Ascendis Pharma's SG&A expenses have surged by over 4,100% from 2014 to 2023, reflecting its aggressive expansion and investment in growth. In contrast, Viking Therapeutics has maintained a more conservative approach, with a 2,900% increase over the same period.
Novartis AG and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Ascendis Pharma A/S
Cost Management Insights: SG&A Expenses for Intra-Cellular Therapies, Inc. and Ascendis Pharma A/S
Insmed Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Ascendis Pharma A/S vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Ascendis Pharma A/S vs Xencor, Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Viking Therapeutics, Inc. vs MannKind Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Xencor, Inc.